Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months
- PMID: 1986022
- DOI: 10.1210/jcem-72-1-223
Effect of a single infusion of aminohydroxypropylidene on calcium and bone metabolism in healthy volunteers monitored during 2 months
Abstract
Recently, bisphosphonates have been used to prevent postmenopausal bone loss. As the effects of bisphosphonates on normal bone metabolism are unknown, 3-amino-1-hydroxypropylidene-1,1-diphosphonate (APD) was studied in healthy subjects. The effects of a single 20-mg APD infusion on biochemical parameters of calcium and bone metabolism were investigated during 2 months in 10 healthy male volunteers. This single moderate dose of APD reduced biochemical parameters of bone resorption during the time of follow-up. After 2 months, urinary hydroxyproline excretion was still below the basal level. The decreased serum calcium levels did not return to basal values. Biochemical parameters of bone formation, serum alkaline phosphatase and osteocalcin, showed a slight increase during the first month after stimulation of the parathyroids and a corresponding increase in serum 1,25-dihydroxyvitamin D. These formation parameters decreased thereafter, probably representing coupling between bone resorption and bone formation.
Similar articles
-
Effect of aminohydroxypropylidene diphosphonate on the bone metabolism of patients with parathyroid adenoma.Horm Metab Res. 1993 Sep;25(9):493-7. doi: 10.1055/s-2007-1002158. Horm Metab Res. 1993. PMID: 8225204
-
Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women.Calcif Tissue Int. 1990 Dec;47(6):332-7. doi: 10.1007/BF02555883. Calcif Tissue Int. 1990. PMID: 2292078
-
Alterations in serum and urine parameters reflecting bone turnover in uremic patients during treatment with 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3.Miner Electrolyte Metab. 1993;19(2):78-85. Miner Electrolyte Metab. 1993. PMID: 8377728
-
Biochemical markers of bone turnover in diagnosis and assessment of therapy.Am J Med. 1991 Nov 25;91(5B):64S-68S. doi: 10.1016/0002-9343(91)90251-r. Am J Med. 1991. PMID: 1750422 Review. No abstract available.
-
Use of calcium tracers and biomarkers to determine calcium kinetics and bone turnover.Bone. 1998 May;22(5 Suppl):103S-104S. doi: 10.1016/s8756-3282(98)00015-5. Bone. 1998. PMID: 9600763 Review.
Cited by
-
Acute effects of bisphosphonates on new and traditional markers of bone resorption.Calcif Tissue Int. 1995 Jul;57(1):25-9. doi: 10.1007/BF00298992. Calcif Tissue Int. 1995. PMID: 7671161
-
Two years' effectiveness of intravenous pamidronate (APD) versus oral fluoride for osteoporosis occurring in the postmenopause.Osteoporos Int. 1994 Mar;4(2):76-83. doi: 10.1007/BF01623227. Osteoporos Int. 1994. PMID: 8003844 Clinical Trial.
-
Adverse effects of bisphosphonates. A comparative review.Drug Saf. 1996 Mar;14(3):158-70. doi: 10.2165/00002018-199614030-00003. Drug Saf. 1996. PMID: 8934578 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials